Bones and Crohn's: Risk factors associated with low bone mineral density in patients with Crohn's disease

Inflammatory Bowel Diseases

Volumn 10, Issue 3, 2004, Pages 220-228

  Siffledeen, Jesse S ^a   Fedorak, Richard N ^a   Siminoski, Kerry ^a   Jen, Ho ^a   Vaudan, Eric ^a   Abraham, Neena ^a   Seinhart, Hillary ^b,c   Greenberg, Gordon ^b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bone mineral density; Crohn's disease; Inflammatory bowel disease; Osteopenia; Osteoporosis

Indexed keywords

BIOCHEMICAL MARKER; CORTICOSTEROID;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD ANALYSIS; BODY MASS; BONE DENSITY; BONE MINERAL; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID INDUCED OSTEOPOROSIS; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; FEMUR NECK; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; OUTPATIENT CARE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RADIUS; RISK FACTOR; SEX DIFFERENCE; THROMBOCYTE COUNT; URINALYSIS;

ADULT; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; CANADA; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RISK FACTORS;

EID: 2442608845     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200405000-00007     Document Type: Article

References (49)

1. Martin JP, Tonge KA, Bhonsle U, et al. Levi J. Bone mineral density in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1999;11:537-541.
2. Bischoff S, Herrmann A, Goke M, et al. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol. 1997;92:1157-1163.
3. Dinca M, Fries W, Luisetto G, et al. Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol. 1999;94:1292-1297.
4. Jahnsen J, Falch JA, Aadland E, et al. Bone mineral density is reduced in patients with Crohn's disease but not in patients with Ulcerative Colitis: a population based study. Gut. 1997;40:313-319.
5. Ghosh S, Cowen S, Hannan J, et al. Low bone mineral density in Crohn's disease, but not in Ulcerative Colitis, at diagnosis. Gastroenterology. 1994;107:1031-1039.
6. Habtezion A, Silverberg MS, Parkes R, et al. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis. 2002;8:87-92.
7. Bernstein CN, Seeger LL, Sayre JW, et al. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. Journal of Bone and Mineral Research. 1995; 10(2):250-256.
8. Vogelsang H, Ferenci P, Resch H, et al. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol. 1995;7:609-614.
9. Vogelsang H, Ferenci P, Woloszczuk W, et al. Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci. 1989;34:1094-1099.
10. Sylvester FA, Wyzga N, Hyams JS, et al. Effect of Crohn's disease on bone metabolism in vitro: A role for Interleukin 6. Journal of Bone and Mineral Research. 2002;17(4):695-702.
11. Robinson RJ, Iqbal SJ, Al-Azzawi F, et al. Sex hormone status and bone metabolism in men with Crohn's disease. Aliment Pharmacol Ther. 1998; 12:21-25.
12. Szathmari M, Vasarhelyi B, Treszl A, et al. Association of dehydroepiandrosterone sulfate deficiency with bone turnover in men with inflammatory bowel disease. Int J Colorectal Dis. 2002;17:63-66.
13. Silvennoinen J, Lehtola J. Niemela S. Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease. Scandanavian Journal of Gastroenterology. 1996;31:367-371.
14. Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut. 1987;28:410-415.
15. Stevens C, Walz G, Singaram C, et al. Tumor necrosis factor alpha, interleukin 1-beta, and interleukin 6 expression in inflammatory bowel disease. Dig Dis Sci. 1992;37:818-826.
16. Dressner-Pollak R, Karmeli F, Eliakim R, et al. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol. 1998; 93:1483-1490.
17. Gordon D, Beastall G, Thomson J, Sturrock R. Androgenic status and sexual function in males with rheumatoid arthritis and ankylosing spondylitis. Q J Med. 1986;231:671-679.
18. Clements D, Compston JE, Evans WD. Rhodes J. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut. 1993;34:1543-1546.
19. World Health Organization Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:1-129.
20. Kanis J.A., Melton III LJ, Christiansen C., et al. The diagnosis of osteoporosis. Journal of Bone and Mineral Research. 1994;9(8):1137-1141.
21. Schott AM, Cormier CC, Hans D, et al. How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS prospective study. Osteoporos Int. 1998;8:247-254.
22. Kanis JA, Johnell O, Oden A, et al. Diagnosis of osteoporosis and fracture threshold in men. Calcif Tissue Int. 2001;69:218-221.
23. Eastell R, Riggs BL, Wahner HW, et al. Colles' fracture and bone density of the ultradistal radius. Journal of Bone and Mineral Research. 1989;4 (4):607-613.
24. Schoon EJ, Van Nunen AB, Wouters RSME, et al. Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort. Scandanavian journal of Gastroenterology. 2000;35(suppl 232): 43-47.
25. Ardizzone S., Bollani S., Bettica P., et al., Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and Ulcerative Colitis. Journal of Internal Medicine. 2000;247: 63-70.
26. Bjarnason I, Macpherson A, Mackintosh C, et al. Reduced bone density in patients with inflammatory bowel disease. Gut. 1997;40:228-233.
27. Bernstein CN, Blanchard JF, Leslie W, et al. The incidence of fracture among patients with inflammatory bowel disease. Ann Intern Med. 2000; 133:795-799.
28. Ross PD, Davis JW, Epstein RS. Wasnich R.D. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991;114:919-923.
29. Vestergaard P, Krogh K, Rejnmark L, et al. Fracture risk is increased in Crohn's disease, but not in Ulcerative Colitis. Gut. 2000;46:176-181.
30. Motley RJ, Crawley EO, Evans C, et al. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut. 1988;29: 1332-1336.
31. Andreassen H, Hylander E. Rix M. Gender, age and body weight are major predictive factors for bone mineral density in Crohn's disease: a case-control cross-sectional study of 113 patients. Am J Gastroenterol. 1999; 94:824-828.
32. Sojka JE. Magnesium supplementation and osteoporosis. Nutr Rev. 1995; 53:71-80.
33. Dressner-Pollak R, Karmeli F, Eliakim R, et al. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. Am J Gastroenterol. 2000;95:699-704.
34. Haugeberg G, Vetvik K, Stallem A, et al. Bone density reduction in patients with Crohn disease and associations with demographic disease variables: cross-sectional data from a population-based study. Scandanavian Journal of Gastroenterology. 2001;36:759-765.
35. Looker AC, Orwoll ES, Johnston CC, et al. Prevalence of low femoral bone density in older US adults from NHANES III. Journal of Bone and Mineral Research. 1997;12:1761-1768.
36. Rosalki SB. C-reactive protein. International Journal of Clinical Practice. 2001;55:269-270.
37. Collins CE. Rampton D.S. Review article: platelets in inflammatory bowel disease-pathogenic role and therapeutic implications. Aliment Pharmacol Ther. 1997;11:237-247.
38. Hanson DA, Weis ME, Bollen AM, et al. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. Journal of Boone and Mineral Research, 1992;7(11):1251-1258.
39. Robinson RJ, Al Azzawi F, Iqbal SJ, et al. Osteoporosis and determinants of bone density in patients with Crohn's disease. Dig Dis Sci. 1998;43: 2500-2506.
40. Manolagas SC. Jilka R.L., Bone marrow, cytokines, and bone remodelling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995;332:305-311.
41. Melton III LJ, Atkinson E.J, O'Connor MK, et al. Bone density and fracture risk in men. Journal of Bone and Mineral Research. 1998; 13:1915-1923.
42. de Laet CE, Van Hout BA, Burger H, et al. Hip fracture prediction in elderly men and women: validation in the Rotterdam study. Journal of Bone and Mineral Research. 1998;13:1587-1593.
43. Cheng S., Suominen H., Sakari-Rantala R., et al. Calcaneal bone mineral density predicts fracture occurence: a five-year follow-up study in elderly people. Journal of Bone and Mineral Research. 1997;12:1075-1082.
44. Marshall D, Johnell O. Wedel H. Meta-analysis of how well measures of bone mineral density predict occurence of osteoporotic fractures. Br Med J. 1996;312:1254-1259.
45. Vestergaard P, Mosekilde L. Fracture risk in patients with Celiac disease, Crohn's disease, and Ulcerative Colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol. 2002;156:1-10.
46. Loftus EVJ, Crowson CS, Sandborn WJ, et al, Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. Gastroenterology. 2002;123:468-475.
47. Kapsoritakis A, Koukourakis MI, Sfiridaki A, et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol. 2001;96:776-781.
48. Silvennoinen J, Risteli L, Karttunen T. Risteli J. Increased degradation of type I collagen in patients with inflammatory bowel disease. Gut. 1996; 38:223-228.
49. Robinson RJ, Iqbal SJ, Abrams K, et al. Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Ther. 1998;12:699-705.